Rx to OTC Switches Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: R8F33205D261EN
Market Monitor Global

Abstracts

While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives.

This report contains market size and forecasts of Rx to OTC Switches in Global, including the following market information:

Global Rx to OTC Switches Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rx to OTC Switches market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Analgesics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rx to OTC Switches include Bayer, C. H. Boehringer Sohn, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rx to OTC Switches companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rx to OTC Switches Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rx to OTC Switches Market Segment Percentages, by Type, 2021 (%)

• Analgesics
• Anti-infectives
• Gastrointestinal Drugs
• Others

Global Rx to OTC Switches Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rx to OTC Switches Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Rx to OTC Switches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rx to OTC Switches Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rx to OTC Switches revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rx to OTC Switches revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• C. H. Boehringer Sohn
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Novartis
• Pfizer
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rx to OTC Switches Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rx to OTC Switches Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RX TO OTC SWITCHES OVERALL MARKET SIZE

2.1 Global Rx to OTC Switches Market Size: 2021 VS 2028
2.2 Global Rx to OTC Switches Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rx to OTC Switches Players in Global Market
3.2 Top Global Rx to OTC Switches Companies Ranked by Revenue
3.3 Global Rx to OTC Switches Revenue by Companies
3.4 Top 3 and Top 5 Rx to OTC Switches Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rx to OTC Switches Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rx to OTC Switches Players in Global Market
  3.6.1 List of Global Tier 1 Rx to OTC Switches Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rx to OTC Switches Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rx to OTC Switches Market Size Markets, 2021 & 2028
  4.1.2 Analgesics
  4.1.3 Anti-infectives
  4.1.4 Gastrointestinal Drugs
  4.1.5 Others
4.2 By Type - Global Rx to OTC Switches Revenue & Forecasts
  4.2.1 By Type - Global Rx to OTC Switches Revenue, 2017-2022
  4.2.2 By Type - Global Rx to OTC Switches Revenue, 2023-2028
  4.2.3 By Type - Global Rx to OTC Switches Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rx to OTC Switches Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Rx to OTC Switches Revenue & Forecasts
  5.2.1 By Application - Global Rx to OTC Switches Revenue, 2017-2022
  5.2.2 By Application - Global Rx to OTC Switches Revenue, 2023-2028
  5.2.3 By Application - Global Rx to OTC Switches Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rx to OTC Switches Market Size, 2021 & 2028
6.2 By Region - Global Rx to OTC Switches Revenue & Forecasts
  6.2.1 By Region - Global Rx to OTC Switches Revenue, 2017-2022
  6.2.2 By Region - Global Rx to OTC Switches Revenue, 2023-2028
  6.2.3 By Region - Global Rx to OTC Switches Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rx to OTC Switches Revenue, 2017-2028
  6.3.2 US Rx to OTC Switches Market Size, 2017-2028
  6.3.3 Canada Rx to OTC Switches Market Size, 2017-2028
  6.3.4 Mexico Rx to OTC Switches Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rx to OTC Switches Revenue, 2017-2028
  6.4.2 Germany Rx to OTC Switches Market Size, 2017-2028
  6.4.3 France Rx to OTC Switches Market Size, 2017-2028
  6.4.4 U.K. Rx to OTC Switches Market Size, 2017-2028
  6.4.5 Italy Rx to OTC Switches Market Size, 2017-2028
  6.4.6 Russia Rx to OTC Switches Market Size, 2017-2028
  6.4.7 Nordic Countries Rx to OTC Switches Market Size, 2017-2028
  6.4.8 Benelux Rx to OTC Switches Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rx to OTC Switches Revenue, 2017-2028
  6.5.2 China Rx to OTC Switches Market Size, 2017-2028
  6.5.3 Japan Rx to OTC Switches Market Size, 2017-2028
  6.5.4 South Korea Rx to OTC Switches Market Size, 2017-2028
  6.5.5 Southeast Asia Rx to OTC Switches Market Size, 2017-2028
  6.5.6 India Rx to OTC Switches Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rx to OTC Switches Revenue, 2017-2028
  6.6.2 Brazil Rx to OTC Switches Market Size, 2017-2028
  6.6.3 Argentina Rx to OTC Switches Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rx to OTC Switches Revenue, 2017-2028
  6.7.2 Turkey Rx to OTC Switches Market Size, 2017-2028
  6.7.3 Israel Rx to OTC Switches Market Size, 2017-2028
  6.7.4 Saudi Arabia Rx to OTC Switches Market Size, 2017-2028
  6.7.5 UAE Rx to OTC Switches Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Rx to OTC Switches Major Product Offerings
  7.1.4 Bayer Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 C. H. Boehringer Sohn
  7.2.1 C. H. Boehringer Sohn Corporate Summary
  7.2.2 C. H. Boehringer Sohn Business Overview
  7.2.3 C. H. Boehringer Sohn Rx to OTC Switches Major Product Offerings
  7.2.4 C. H. Boehringer Sohn Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.2.5 C. H. Boehringer Sohn Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Rx to OTC Switches Major Product Offerings
  7.3.4 GlaxoSmithKline Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Rx to OTC Switches Major Product Offerings
  7.4.4 Johnson & Johnson Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Rx to OTC Switches Major Product Offerings
  7.5.4 Merck Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Rx to OTC Switches Major Product Offerings
  7.6.4 Novartis Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Rx to OTC Switches Major Product Offerings
  7.7.4 Pfizer Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Rx to OTC Switches Major Product Offerings
  7.8.4 Sanofi Rx to OTC Switches Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rx to OTC Switches Market Opportunities & Trends in Global Market
Table 2. Rx to OTC Switches Market Drivers in Global Market
Table 3. Rx to OTC Switches Market Restraints in Global Market
Table 4. Key Players of Rx to OTC Switches in Global Market
Table 5. Top Rx to OTC Switches Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rx to OTC Switches Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rx to OTC Switches Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rx to OTC Switches Product Type
Table 9. List of Global Tier 1 Rx to OTC Switches Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rx to OTC Switches Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rx to OTC Switches Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rx to OTC Switches Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rx to OTC Switches Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rx to OTC Switches Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rx to OTC Switches Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rx to OTC Switches Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rx to OTC Switches Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rx to OTC Switches Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rx to OTC Switches Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rx to OTC Switches Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rx to OTC Switches Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rx to OTC Switches Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rx to OTC Switches Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rx to OTC Switches Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rx to OTC Switches Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rx to OTC Switches Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rx to OTC Switches Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rx to OTC Switches Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rx to OTC Switches Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Rx to OTC Switches Product Offerings
Table 32. Bayer Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 33. C. H. Boehringer Sohn Corporate Summary
Table 34. C. H. Boehringer Sohn Rx to OTC Switches Product Offerings
Table 35. C. H. Boehringer Sohn Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Rx to OTC Switches Product Offerings
Table 38. GlaxoSmithKline Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Rx to OTC Switches Product Offerings
Table 41. Johnson & Johnson Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Rx to OTC Switches Product Offerings
Table 44. Merck Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Rx to OTC Switches Product Offerings
Table 47. Novartis Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Rx to OTC Switches Product Offerings
Table 50. Pfizer Rx to OTC Switches Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Rx to OTC Switches Product Offerings
Table 53. Sanofi Rx to OTC Switches Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rx to OTC Switches Segment by Type in 2021
Figure 2. Rx to OTC Switches Segment by Application in 2021
Figure 3. Global Rx to OTC Switches Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rx to OTC Switches Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rx to OTC Switches Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rx to OTC Switches Revenue in 2021
Figure 8. By Type - Global Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 12. US Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 16. Germany Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 17. France Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 24. China Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 28. India Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 30. Brazil Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rx to OTC Switches Revenue Market Share, 2017-2028
Figure 33. Turkey Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rx to OTC Switches Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. C. H. Boehringer Sohn Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Rx to OTC Switches Revenue Year Over Year Growth (US$, Mn) & (2017-2022)